跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
PMS-NYSTATIN SUSPENSION 500,000 U/5 ML
Approved
THERAPEUTIC
PMS-NYSTATIN SUSPENSION 500,000 U/5 ML
PENDOPHARM - CANADAHALO PHARMACEUTICAL CANADA INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 22, 1991
Approval ID
28062f7917769b89
Company
PENDOPHARM - CANADAHALO PHARMACEUTICAL CANADA INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
28062f7917769b89
Drug Name
PMS-NYSTATIN SUSPENSION 500,000 U/5 ML
Product Name
PMS-NYSTATIN SUSPENSION 500,000 U/5 ML
Approval Number
SIN05499P
Approval Date
1991-02-22
Registrant
SYNMOSA BIOPHARMA PTE. LTD.
Licence Holder
SYNMOSA BIOPHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SUSPENSION
Route Of Administration
ORAL
Atc Code
A07AA02
Atc Item Name
nystatin
Pharma Manufacturer Name
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Active Ingredients
NYSTATIN
500000 u/5 ml
NYSTATIN
500000 u/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 22, 1991
Approval ID
28062f7917769b89
Type
Therapeutic
Back to HSA Approvals
PMS-NYSTATIN SUSPENSION 500,000 U/5 ML - HSA Drug Approval Details